Beximco gets FDA approval for generic anti-allergy drug
24th Apr 2019 15:41
(Sharecast News) - Beximco Pharmaceuticals announced on Wednesday that it has received US Food and Drug Administration (FDA) approval for its cyproheptadine hydrochloride tablet 4mg anti-allergy drug, which is a generic equivalent to 'Periactin' 4mg tablets from Merck and Company.
Read moreBeximco adds to US portfolio with purchase of Novartis assets
20th Feb 2019 14:46
(Sharecast News) - Generic drugs manufacturer Beximco Pharmaceuticals announced the signing of a definitive agreement with Sandoz - a division of Novartis - to acquire a portfolio of eight 'Abbreviated New Drug Applications' (ANDAs) in the US on Wednesday, for an undisclosed amount in cash.
Read moreMonday broker round-up
30th Jul 2018 13:17
(Sharecast News) - Sophos Group: Numis upgrades to add with a target price of 580p.
Read moreMonday broker round-up
23rd Jul 2018 12:53
(Sharecast News) - Hargreaves Lansdown: Jefferies downgrades to underperform with a target price of 1,650p.
Read moreBeximco profits rise as it begins US exports
27th Jan 2017 10:45
(ShareCast News) - Bangladeshi generic pharmaceutical products and active pharmaceutical ingredients manufacturer Beximco Pharmaceuticals announced its unaudited financial results for the six months to 31 December on Friday. The AIM-traded company said net sales increased by 13.6% to BDT 7,630.6m or
Read moreBeximco Pharma partners with BioCare in Malaysia
25th Jan 2017 16:10
(ShareCast News) - Generic pharmaceutical products manufacturer Beximco Pharmaceuticals announced the creation of a joint venture with BioCare Manufacturing, based in Malaysia, as the company's first overseas manufacturing collaboration on Wednesday. The AIM-traded firm said that under the terms of
Read moreBeximco sales grow in first half
20th Oct 2016 11:01
(ShareCast News) - Generic pharmaceutical products and active ingredients manufacturer Beximco Pharmaceuticals posted audited results for the half year to 30 June on Thursday, with net sales growing by 13.1% to BDT 7.07bn. The AIM-traded firm's export sales grew by 5.3%, and domestic market sales in
Read moreBeximco makes historic drug shipment to Kuwait
17th Jun 2016 15:21
(ShareCast News) - Generic pharmaceutical manufacturer Beximco announced on Friday that it has commenced the export of pharmaceuticals to Kuwait. The AIM-traded firm said it marks the first time a Bangladeshi pharmaceutical company has launched products in any Gulf member country under the Gulf Coop
Read more